($71.01 vs. $68.86 on Oct. 22) traded as low as $66.72 on Oct. 28 and now is poised just below its 50-day SMA at $71.50. My weekly value level is $66.82 with a semiannual risky level at $73.01.
WellCare Health Plans
($67.47 vs. $70.00 on Oct. 22) traded down to a test of its 200-day SMA at $60.05 on Nov. 1 then rebounded to its 50-day SMA at $68.59. My quarterly value level is $60.56 with a weekly pivot at $67.04 with an annual risky level at $69.44.
($88.02 vs. $88.43 on Oct. 22) traded down to $83.13 on Oct. 24 then as high as $88.50 on Nov. 7 above its 50-day SMA at $86.40. Buy-and-trade investors could have bought this stock at my weekly and semiannual value levels at $85.96 and $83.77. Today my semiannual value level remains at $83.77 with a monthly risky level at $98.24.
At the time of publication the author held no positions in any of the stocks mentioned.
This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.